The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

PHPT1  -  phosphohistidine phosphatase 1

Homo sapiens

Synonyms: 14 kDa phosphohistidine phosphatase, CGI-202, DKFZp564M173, HEL-S-132P, HSPC141, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of PHPT1

  • A subset of families are likely to be genetic variants of other familial tumour syndromes in which PHPT is the main feature, for example multiple endocrine neoplasia type 1 (MEN 1) and the hyperparathyroidism-jaw tumour syndrome (HPT-JT) [1].
  • Medical treatment is debatable under other circumstances: mild chronic hypercalcemia, patients who refuse surgery, serious coexisting medical problems and recurrence or persistence of PHPT after surgical treatment [2].
  • Both in primary (PHPT) and secondary hyperparathyroidism (SHPT) PTH excess is thought to be involved in deteriorating insulin sensitivity and secretion though their different clinical and pathophysiological conditions [3].
  • In PHPT these abnormalities are related to a high frequency of Type 2 diabetes mellitus and also impaired glucose tolerance according to recent clinical studies, without differences between symptomatic and asymptomatic clinical presentation [3].
  • Video-assisted neck exploration was conducted in all cases under general anaesthesia leading to a partial or total thyroidectomy, and to a selective adenoma removal in PHPT or to a subtotal parathyroid resection in SHPT [4].
 

High impact information on PHPT1

  • The structure of phosphohistidine phosphatase (PHPT1), the first identified eukaryotic-protein histidine phosphatase, has been determined to a resolution of 1.9A using multiple-wavelength anomalous dispersion methods [5].
  • Bone density, serum calcium concentration, and/or urinary calcium excretion per se can show evidence for progression in as many as 25% of patients with asymptomatic PHPT [6].
  • The bone formation rate was significantly higher in PHPT than in either OP or N, and not different between OP and N [7].
  • These findings suggest that mild PHPT protects against the loss of cancellous bone structure that normally follows menopause [7].
  • Global gene expression profiling has been used to study the molecular mechanisms of increased bone remodeling caused by PHPT [8].
 

Chemical compound and disease context of PHPT1

  • The PHPT patients who died differed from the whole PHPT material in higher mean age at operation (61 years v. 53 years), higher preoperative serum calcium values (3.31 mmol/l v. 3.08 mmol/l), more frequently elevated serum creatine preoperatively (44% v. 17%) and higher mean weight of the removed adenomas (3300 mg v. 2000 mg) [9].
 

Biological context of PHPT1

 

Anatomical context of PHPT1

 

Associations of PHPT1 with chemical compounds

 

Analytical, diagnostic and therapeutic context of PHPT1

  • For these reasons, parathyroidectomy should generally be recommended for patients with a secure diagnosis of PHPT, even in the absence of classical symptoms [13].
  • We analyzed mRNAs in transiliacal bone biopsies from 7 patients with PHPT using Affymetrix HG-U133A Gene Chips containing more than 22000 different probe sets [8].
  • The prevalence of PHPT in the control group was 1.25% [12].
  • In all cases, video-assisted neck exploration was performed under general anesthesia, leading to selective adenoma removal in PHPT or subtotal parathyroid resection in SHPT [14].
  • METHODS: Twenty-two patients aged 70 years and over with biochemically proven PHPT and with a single parathyroid adenoma identified by localization studies (sestamibi SPECT scan and ultrasonography) underwent 23 operations over 29 months (out of a total of 140 patients operated upon during the same period) [15].

References

  1. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. Villablanca, A., Wassif, W.S., Smith, T., Höög, A., Vierimaa, O., Kassem, M., Dwight, T., Forsberg, L., Du, Q., Learoyd, D., Jones, K., Stranks, S., Juhlin, C., Teh, B.T., Carling, T., Robinson, B., Larsson, C. Eur. J. Endocrinol. (2002) [Pubmed]
  2. Possibilities and limits of the medical treatment for primary hyperparathyroidism. Lefebvre, J. Horm. Res. (1989) [Pubmed]
  3. Derangement of glucose metabolism in hyperparathyroidism. Procopio, M., Borretta, G. J. Endocrinol. Invest. (2003) [Pubmed]
  4. Contributions of the video-assisted approach to thyroid and parathyroid surgery. Mourad, M., Pugin, F., Elias, B., Malaise, J., Coche, E., Jamar, F., Maiter, D., Daumerie, C.h., Squifflet, J.P. Acta chirurgica Belgica. (2002) [Pubmed]
  5. First structure of a eukaryotic phosphohistidine phosphatase. Busam, R.D., Thorsell, A.G., Flores, A., Hammarstr??m, M., Persson, C., Hallberg, B.M. J. Biol. Chem. (2006) [Pubmed]
  6. Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future. Bilezikian, J.P., Potts, J.T. J. Bone Miner. Res. (2002) [Pubmed]
  7. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. Parisien, M., Cosman, F., Mellish, R.W., Schnitzer, M., Nieves, J., Silverberg, S.J., Shane, E., Kimmel, D., Recker, R.R., Bilezikian, J.P. J. Bone Miner. Res. (1995) [Pubmed]
  8. Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Reppe, S., Stilgren, L., Olstad, O.K., Brixen, K., Nissen-Meyer, L.S., Gautvik, K.M., Abrahamsen, B. Bone (2006) [Pubmed]
  9. Causes of death in patients previously operated on for primary hyperparathyroidism. Ronni-Sivula, H. Annales chirurgiae et gynaecologiae. (1985) [Pubmed]
  10. Mutational study of human phosphohistidine phosphatase: effect on enzymatic activity. Ma, R., Kanders, E., Sundh, U.B., Geng, M., Ek, P., Zetterqvist, O., Li, J.P. Biochem. Biophys. Res. Commun. (2005) [Pubmed]
  11. Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase. Ek, P., Pettersson, G., Ek, B., Gong, F., Li, J.P., Zetterqvist, O. Eur. J. Biochem. (2002) [Pubmed]
  12. The state of health of patients previously operated on for primary hyperparathyroidism compared with randomized controls. Ronni-Sivula, H. Annales chirurgiae et gynaecologiae. (1985) [Pubmed]
  13. Therapeutic controversies in primary hyperparathyroidism. Silverberg, S.J., Bilezikian, J.P., Bone, H.G., Talpos, G.B., Horwitz, M.J., Stewart, A.F. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  14. Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience. Mourad, M., Ngongang, C., Saab, N., Coche, E., Jamar, F., Michel, J.M., Maiter, D., Malaise, J., Squifflet, J.P. Surgical endoscopy. (2001) [Pubmed]
  15. Focused, minimally invasive radio-guided parathyroidectomy: a feasible and safe option for elderly patients with primary hyperparathyroidism. Ben Haim, M., Zwas, S.T., Munz, Y., Rosin, D., Shabtai, E.L., Kuriansky, J., Olchovsky, D., Zmora, O., Scarlat, A., Ayalon, A., Shabtai, M. Isr. Med. Assoc. J. (2003) [Pubmed]
 
WikiGenes - Universities